.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Express Scripts
Chubb
Fish and Richardson
UBS
Colorcon
McKesson
Covington
Baxter
Harvard Business School

Generated: November 24, 2017

DrugPatentWatch Database Preview

TOBRADEX Drug Profile

« Back to Dashboard

Which patents cover Tobradex, and what generic Tobradex alternatives are available?

Tobradex is a drug marketed by Novartis Pharms Corp and is included in three NDAs. There are three patents protecting this drug.

The generic ingredient in TOBRADEX is dexamethasone; tobramycin. There are thirty-nine drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the dexamethasone; tobramycin profile page.
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis Pharms Corp
TOBRADEX
dexamethasone; tobramycin
OINTMENT;OPHTHALMIC050616-001Sep 28, 1988RXYesYes► Subscribe► Subscribe► Subscribe
Novartis Pharms Corp
TOBRADEX ST
dexamethasone; tobramycin
SUSPENSION/DROPS;OPHTHALMIC050818-001Feb 13, 2009RXYesYes► Subscribe► SubscribeY ► Subscribe
Novartis Pharms Corp
TOBRADEX
dexamethasone; tobramycin
SUSPENSION/DROPS;OPHTHALMIC050592-001Aug 18, 1988ABRXYesYes► Subscribe► Subscribe► Subscribe
Novartis Pharms Corp
TOBRADEX ST
dexamethasone; tobramycin
SUSPENSION/DROPS;OPHTHALMIC050818-001Feb 13, 2009RXYesYes► Subscribe► SubscribeY ► Subscribe
Novartis Pharms Corp
TOBRADEX ST
dexamethasone; tobramycin
SUSPENSION/DROPS;OPHTHALMIC050818-001Feb 13, 2009RXYesYes► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: TOBRADEX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis Pharms Corp
TOBRADEX
dexamethasone; tobramycin
OINTMENT;OPHTHALMIC050616-001Sep 28, 1988► Subscribe► Subscribe
Novartis Pharms Corp
TOBRADEX
dexamethasone; tobramycin
SUSPENSION/DROPS;OPHTHALMIC050592-001Aug 18, 1988► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
Deloitte
Merck
US Department of Justice
Accenture
Julphar
Boehringer Ingelheim
McKinsey
Daiichi Sankyo
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot